Department of Pharmacy, Yamagata University Hospital, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan.
Int J Mol Sci. 2022 Jun 11;23(12):6542. doi: 10.3390/ijms23126542.
Dementia dramatically affects the activities of daily living and quality of life; thus, many therapeutic approaches for overcoming dementia have been developed. However, an effective treatment regimen is yet to be developed. As diabetes is a well-known risk factor for dementia, drug repositioning and repurposing of antidiabetic drugs are expected to be effective dementia treatments. Several observational studies have been useful for understanding the effectiveness of antidiabetic drugs in treating dementia, but it is difficult to conclusively analyze the association between antidiabetic drug treatment and the risk of developing dementia after correcting for potential confounding factors. Mechanism-based approaches may provide a better understanding of the effectiveness of antidiabetic drugs for treating dementia. Since the peripheral circulation and the central nerve system are separated by the blood-brain barrier, it is important to understand the regulation of the central glucose metabolism. In this review, we discuss the pharmacological and pharmacokinetic properties of antidiabetic drugs in relation to treating dementia.
痴呆症严重影响日常生活活动和生活质量;因此,已经开发出许多克服痴呆症的治疗方法。然而,有效的治疗方案尚未开发出来。由于糖尿病是痴呆症的一个已知危险因素,因此,抗糖尿病药物的药物重定位和再利用有望成为有效的痴呆症治疗方法。一些观察性研究有助于了解抗糖尿病药物治疗痴呆症的有效性,但在纠正潜在混杂因素后,很难对抗糖尿病药物治疗与痴呆症发病风险之间的关联进行结论性分析。基于机制的方法可能会更好地理解抗糖尿病药物治疗痴呆症的效果。由于外周循环和中枢神经系统被血脑屏障隔开,因此了解中枢葡萄糖代谢的调节非常重要。在这篇综述中,我们讨论了抗糖尿病药物在治疗痴呆症方面的药理学和药代动力学特性。